PE120499A1 - Polimorfo antifungico cristalino - Google Patents

Polimorfo antifungico cristalino

Info

Publication number
PE120499A1
PE120499A1 PE1998000942A PE00094298A PE120499A1 PE 120499 A1 PE120499 A1 PE 120499A1 PE 1998000942 A PE1998000942 A PE 1998000942A PE 00094298 A PE00094298 A PE 00094298A PE 120499 A1 PE120499 A1 PE 120499A1
Authority
PE
Peru
Prior art keywords
crystalline polymorph
antifungal
fenil
triazol
hydroxylpropil
Prior art date
Application number
PE1998000942A
Other languages
English (en)
Spanish (es)
Inventor
R Andrews David
Leong William
Sudhakar Anantha
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE120499A1 publication Critical patent/PE120499A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PE1998000942A 1997-10-07 1998-10-05 Polimorfo antifungico cristalino PE120499A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07

Publications (1)

Publication Number Publication Date
PE120499A1 true PE120499A1 (es) 1999-12-04

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000942A PE120499A1 (es) 1997-10-07 1998-10-05 Polimorfo antifungico cristalino

Country Status (30)

Country Link
EP (1) EP1021439B1 (enExample)
JP (4) JP2001519346A (enExample)
KR (1) KR100626109B1 (enExample)
CN (1) CN1125067C (enExample)
AR (1) AR015947A1 (enExample)
AT (1) ATE263163T1 (enExample)
AU (1) AU759982B2 (enExample)
BR (1) BR9812866A (enExample)
CA (1) CA2305803C (enExample)
CO (1) CO4970829A1 (enExample)
CZ (1) CZ299835B6 (enExample)
DE (1) DE69822859T2 (enExample)
DK (1) DK1021439T3 (enExample)
ES (1) ES2217594T3 (enExample)
HU (1) HU225233B1 (enExample)
ID (1) ID29290A (enExample)
IL (1) IL135331A (enExample)
IN (1) IN1998CH02232A (enExample)
MX (1) MX225999B (enExample)
MY (1) MY130126A (enExample)
NO (1) NO318827B1 (enExample)
NZ (1) NZ503662A (enExample)
PE (1) PE120499A1 (enExample)
PH (1) PH11998002606B1 (enExample)
PL (1) PL189317B1 (enExample)
PT (1) PT1021439E (enExample)
SK (1) SK285190B6 (enExample)
TW (1) TW589310B (enExample)
WO (1) WO1999018097A1 (enExample)
ZA (1) ZA989063B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
BR112012029227B1 (pt) * 2010-05-19 2020-01-07 Sandoz Ag Processo para a preparação de um composto quiral, composto quiral e uso de um composto
CN102892763B (zh) 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
CN102892750B (zh) 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
BR112012029226A2 (pt) 2010-05-19 2015-10-20 Sandoz Ag processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
EP2758385B1 (en) * 2011-09-19 2018-03-28 MSN Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
US9670188B2 (en) 2013-07-25 2017-06-06 Sandoz Ag Process for the preparation of crystalline form IV of posaconazole
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
HRP20201343T1 (hr) 2014-10-21 2020-11-27 Ariad Pharmaceuticals, Inc. Kristalni oblici 5-kloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
EP3331501B1 (en) 2015-08-08 2019-09-11 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole
CA3009610C (en) 2015-12-24 2024-02-13 Takeda Pharmaceutical Company Limited Cocrystal of (s)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1h-1,2,4-triazol-5(4h)-one, production method thereof and pharmaceutical composition containing said cocrystal
EP3210599B1 (en) 2016-02-26 2024-08-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
EP4181883B1 (en) 2021-11-25 2025-11-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
SK283035B6 (sk) * 1993-12-21 2003-02-04 Schering Corporation Tetrahydrofuránová zlúčenina, spôsob jej prípravy, jej farmaceuticky prijateľný ester, soľ a farmaceutický prostriedok
CN1078210C (zh) * 1994-01-24 2002-01-23 詹森药业有限公司 水溶性吡咯系杀真菌剂
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
PL319635A1 (en) * 1995-06-02 1997-08-18 Schering Corp Tetrahydrofurane-based antimycotic agents

Also Published As

Publication number Publication date
DK1021439T3 (da) 2004-05-10
NO20001779D0 (no) 2000-04-06
PT1021439E (pt) 2004-07-30
NO318827B1 (no) 2005-05-09
MX225999B (es) 2005-02-02
IN1998CH02232A (enExample) 2005-03-04
HK1029588A1 (en) 2001-04-06
PH11998002606B1 (en) 2006-08-10
CN1281449A (zh) 2001-01-24
NZ503662A (en) 2002-10-25
EP1021439A1 (en) 2000-07-26
ID29290A (id) 2001-08-16
ES2217594T3 (es) 2004-11-01
HU225233B1 (en) 2006-08-28
CZ299835B6 (cs) 2008-12-10
CZ20001264A3 (cs) 2000-08-16
AR015947A1 (es) 2001-05-30
KR20010030959A (ko) 2001-04-16
AU9780398A (en) 1999-04-27
PL339659A1 (en) 2001-01-02
CN1125067C (zh) 2003-10-22
HUP0004899A3 (en) 2002-03-28
WO1999018097A1 (en) 1999-04-15
CA2305803C (en) 2009-12-22
PL189317B1 (pl) 2005-07-29
SK285190B6 (sk) 2006-08-03
SK5122000A3 (en) 2000-09-12
MXPA00003404A (es) 2000-11-01
CA2305803A1 (en) 1999-04-15
JP2008106075A (ja) 2008-05-08
ZA989063B (en) 1999-04-06
IL135331A0 (en) 2001-05-20
DE69822859D1 (de) 2004-05-06
DE69822859T2 (de) 2005-01-27
EP1021439B1 (en) 2004-03-31
JP2012153730A (ja) 2012-08-16
JP2001519346A (ja) 2001-10-23
NO20001779L (no) 2000-06-06
KR100626109B1 (ko) 2006-09-20
HUP0004899A2 (hu) 2002-02-28
ATE263163T1 (de) 2004-04-15
TW589310B (en) 2004-06-01
AU759982B2 (en) 2003-05-01
IL135331A (en) 2005-08-31
MY130126A (en) 2007-06-29
BR9812866A (pt) 2000-08-08
JP2012153729A (ja) 2012-08-16
CO4970829A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
PE120499A1 (es) Polimorfo antifungico cristalino
BR9910621A (pt) Novos compostos de imidazol 2-alquil substituìdos
TR200401735T4 (tr) Giraz önleyicileri ve bunların kullanımları
MA30652B1 (fr) Composes organiques
KR950005825A (ko) 4-아미노피리미딘 유도체
BR0010020A (pt) Material não tramado com alto relevo e método de fabricação do mesmo
BR0212477A (pt) 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças
DK0424059T3 (da) Anvendelse af substituerede imidazoler
BR0312775A (pt) Documento de valor
BR9102432A (pt) Processo para o tratamento fungicida foliar e composicao fungicida para a realizacao do processo
BR0313763A (pt) Imidazóis 2,4,5-trissubstituìdos e seu uso como agentes antimicrobianos
DE2967005D1 (en) 2-alkoxycarbonylamino benzimidazoles having a halogen-containing substituent, their preparation and their use as parasiticides
BR0108990A (pt) Processo para preparação de derivados de pirimidona com atividade antifungos
PE20050950A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
MXPA01008672A (es) Nuevos compuestos heterociclicos de bencensulfonamida, procedimiento de preparacion y utilizacion en terapeutica.
CO4940463A1 (es) Macrolidas cristalinas
DK0681030T3 (da) Anvendelse af phosphoniumforbindelser ved fremstilling af læder
TR200401347T4 (tr) Yün materyalleri işlemek için silikon bileşikler
ES2176758T3 (es) Procedimiento para la preparacion de 4-ciona-1,2,3-triazxoles.
WO2003086271A3 (en) Azole derivatives as antifungal agents
BR0210701A (pt) Derivados de halofenila intermediária e seu uso em um processo para a preparação de derivados de azol
ES8503680A1 (es) Un procedimiento para la preparacion de un compuesto dotado de propiedades fungicidas
YU3701A (sh) Supstituisani fenilamidini sa antitrombskim dejstvom
ATE262339T1 (de) Purinriboside als antiarrhythmika
PT80628B (en) Process for preparing 4(5)-substituted imidazoles

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term